Latest Divestments News

Aeris Resources reported solid Q1 FY26 results with steady copper and gold production, disciplined cost management, and advancing divestment plans for non-core assets.

MedAdvisor Solutions reported a steep 52.8% revenue decline in Q1 FY26, impacted by US regulatory pressures and vaccine program delays, while embarking on a strategic transformation to restore growth.

Woodside Energy has raised its 2025 production guidance following a 1% increase in quarterly output, while progressing key projects like Scarborough and Beaumont New Ammonia on schedule. The company also secured long-term LNG supply deals and received critical regulatory approvals.

Miramar Resources has granted Future Battery Minerals an exclusive option to acquire its Randalls Project for up to A$800,000, enabling a strategic refocus on its core gold and critical minerals assets.

BPM Minerals has secured the Forelands Gold Project with promising high-grade intercepts and divested its Claw Gold Project to Capricorn Metals, bolstering its cash position ahead of upcoming drilling.

Moho Resources has raised $2 million through a share placement to fund an extensive drilling and sampling campaign at its Bush Chook Project, aiming to validate historical gold anomalies and expand its resource base.

Galan Lithium has secured new exploration licences adjacent to the world-class Greenbushes lithium mine, setting the stage for a targeted Australian exploration program alongside its flagship Argentine projects.

South32 reported a robust September quarter with a 12% rise in copper equivalent production and a 33% surge in manganese volumes, while advancing key projects and maintaining full-year guidance.

Flynn Gold Limited has reported significant progress in its Tasmanian gold exploration projects, including new high-grade gold discoveries and a successful $5 million capital raise to fund further drilling and development.

Arika Resources has agreed to sell its Admiral Bay Zinc Project for $1.15 million upfront, unlocking capital to accelerate drilling at its promising gold projects in Western Australia.

Prodigy Gold has reported a milestone with over one million ounces of gold in its resource inventory, alongside significant exploration progress and a successful $7.13 million capital raise to fund ongoing development.

Vectus Biosystems has agreed to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics for US$3 million in shares and warrants, gaining a strategic equity position while refocusing on its cardiovascular and fibrosis pipeline.